INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
IART on Nasdaq
Shares outstanding
77,575,733
Price per share
$12.42
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
72,862,586
Total reported value
$1,043,959,806
% of total 13F portfolios
0%
Share change
-491,180
Value change
-$4,250,614
Number of holders
205
Price from insider filings
$12.42
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13% $126,168,790 10,282,705 BlackRock, Inc. 30 Jun 2025
Rubric Capital Management LP 9.5% +58% $90,232,770 +$33,254,915 7,353,934 +58% Rubric Capital Management LP 30 Jun 2025
Invesco Ltd. 4.5% -16% $50,024,712 -$8,895,949 3,490,908 -15% Invesco Ltd. 30 Sep 2025
MORGAN STANLEY 4.3% $42,546,659 3,379,401 Morgan Stanley 30 Jun 2025

As of 30 Sep 2025, 205 institutional investors reported holding 72,862,586 shares of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART). This represents 94% of the company’s total 77,575,733 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) together control 79% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 13% 10,229,183 -1.2% 0% $146,584,192
Rubric Capital Management LP 9.9% 7,653,934 +4.1% 1.5% $109,680,874
VANGUARD GROUP INC 9.5% 7,379,127 -2.6% 0% $105,742,890
FULLER & THALER ASSET MANAGEMENT, INC. 5% 3,914,438 +0.56% 0.19% $56,093,904
MORGAN STANLEY 4.9% 3,824,662 -2.8% 0% $54,807,421
Invesco Ltd. 4.5% 3,490,908 -1.3% 0.01% $50,024,711
DIMENSIONAL FUND ADVISORS LP 4.1% 3,184,726 +9.2% 0.01% $45,634,196
STATE STREET CORP 3.6% 2,790,898 -1.3% 0% $39,993,568
PARADIGM CAPITAL MANAGEMENT INC/NY 3.3% 2,529,800 +16% 1.6% $36,252,034
GEODE CAPITAL MANAGEMENT, LLC 2% 1,548,221 -5.7% 0% $22,189,774
NEUBERGER BERMAN GROUP LLC 2% 1,535,184 +79% 0.02% $21,953,995
GOLDMAN SACHS GROUP INC 2% 1,532,334 -11% 0% $21,958,347
Soleus Capital Management, L.P. 1.9% 1,440,818 +3.8% 1.1% $20,646,922
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.8% 1,390,046 +14% 0% $19,919,359
WELLINGTON MANAGEMENT GROUP LLP 1.7% 1,321,275 -0.19% 0% $18,933,871
SYSTEMATIC FINANCIAL MANAGEMENT LP 1.4% 1,060,505 +0.34% 0.37% $15,197,049
J. Goldman & Co LP 1.2% 950,811 +170% 0.52% $13,625,122
Glenmede Investment Management, LP 1.1% 842,430 +23% 0.06% $12,072,021
NORTHERN TRUST CORP 1% 814,339 +9.6% 0% $11,669,478
DEERFIELD MANAGEMENT COMPANY, L.P. 1% 794,865 0% 0.17% $11,390,415
Kent Lake PR LLC 0.97% 752,086 5.5% $10,777,392
D. E. Shaw & Co., Inc. 0.81% 625,151 -6.5% 0.01% $8,958,414
BANK OF AMERICA CORP /DE/ 0.8% 624,080 -5.5% 0% $8,943,065
Invenomic Capital Management LP 0.76% 592,212 +7.2% 0.44% $8,486,398
JPMORGAN CHASE & CO 0.71% 551,732 -3.7% 0% $7,906,320

Institutional Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,076,452 $13,378,674 +$5,684,970 $12.42 13
2025 Q3 72,862,586 $1,043,959,806 -$4,250,614 $14.33 205
2025 Q2 73,128,875 $897,334,015 -$36,927,297 $12.27 208
2025 Q1 73,527,026 $1,616,422,067 +$95,408,342 $21.99 217
2024 Q4 69,341,057 $1,572,669,168 +$40,392,223 $22.68 221
2024 Q3 68,356,958 $1,241,956,268 -$123,869,325 $18.17 221
2024 Q2 70,995,999 $2,068,211,745 +$111,506,222 $29.14 236
2024 Q1 65,939,547 $2,336,158,778 -$70,993,946 $35.45 276
2023 Q4 66,935,797 $2,915,003,332 -$77,019,585 $43.55 283
2023 Q3 68,807,037 $2,627,769,882 -$14,108,008 $38.19 261
2023 Q2 68,833,788 $2,831,315,238 -$177,674,783 $41.13 276
2023 Q1 72,805,512 $4,179,487,921 -$119,683,717 $57.41 276
2022 Q4 74,882,267 $4,198,618,336 +$359,984,223 $56.07 274
2022 Q3 73,865,761 $3,129,594,394 +$18,803,141 $42.36 267
2022 Q2 73,142,507 $3,952,123,032 -$58,765,680 $54.03 274
2022 Q1 74,668,149 $4,798,437,509 -$193,114,447 $64.26 270
2021 Q4 77,374,227 $5,183,843,022 +$22,566,888 $66.99 266
2021 Q3 76,845,573 $5,262,770,593 +$142,772,975 $68.48 249
2021 Q2 74,753,608 $5,101,379,862 +$63,654,057 $68.24 256
2021 Q1 73,827,696 $5,100,654,311 -$19,956,840 $69.09 251
2020 Q4 74,131,946 $4,812,746,680 +$106,065,718 $64.92 242
2020 Q3 72,733,580 $3,434,003,702 +$24,582,537 $47.22 227
2020 Q2 72,219,818 $3,393,083,524 +$38,047,204 $46.99 258
2020 Q1 71,479,610 $3,192,886,669 +$34,470,345 $44.67 247
2019 Q4 70,364,906 $4,099,283,513 +$75,399,570 $58.28 274
2019 Q3 69,015,816 $4,145,110,027 -$76,072,690 $60.07 275
2019 Q2 70,561,261 $3,940,514,537 -$15,762,042 $55.85 259
2019 Q1 71,064,268 $3,959,587,245 -$9,689,665 $55.72 253
2018 Q4 71,356,644 $3,218,096,781 -$145,598,929 $45.10 240
2018 Q3 73,932,903 $4,869,782,048 +$89,857,037 $65.87 244
2018 Q2 72,574,623 $4,674,472,991 +$136,126,765 $64.41 254
2018 Q1 70,538,509 $3,895,446,380 -$37,428,363 $55.34 235
2017 Q4 71,381,479 $3,416,873,181 +$94,615,746 $47.86 216
2017 Q3 69,270,601 $3,495,509,688 +$121,690,078 $50.48 210
2017 Q2 65,649,939 $3,578,707,000 +$89,227,934 $54.51 219
2017 Q1 68,277,066 $2,876,671,699 +$1,525,324,365 $42.13 235
2016 Q4 34,354,608 $2,947,291,687 +$110,723,053 $85.79 211
2016 Q3 33,315,137 $2,746,452,668 +$50,266,706 $82.55 229
2016 Q2 33,433,531 $2,667,800,330 +$55,402,892 $79.78 205
2016 Q1 32,921,033 $2,216,938,120 +$101,821,105 $67.36 191
2015 Q4 31,272,535 $2,119,838,593 +$35,231,298 $67.78 180
2015 Q3 30,860,498 $1,837,736,938 +$220,205,694 $59.55 186
2015 Q2 27,117,903 $1,825,356,069 -$24,330,123 $67.37 185
2015 Q1 27,570,371 $1,699,004,280 +$73,613,124 $61.65 168
2014 Q4 26,421,445 $1,433,122,011 +$6,254,484 $54.23 157
2014 Q3 26,283,530 $1,304,707,409 +$5,504,855 $49.64 140
2014 Q2 26,179,617 $1,232,004,241 +$22,686,057 $47.06 143
2014 Q1 25,688,355 $1,181,326,055 +$18,994,215 $45.99 139